WEB-17装置治疗颅内动脉瘤:12个月血管造影与临床结果
这项回顾性双中心研究分析了WEB-17装置治疗破裂、未破裂及复发颅内动脉瘤的可行性、安全性和12个月疗效。
要点
- WEB-17治疗颅内动脉瘤可行性高(95.3%),但载瘤动脉与动脉瘤主轴夹角≥45°时可行性降低。
- 12个月总体充分闭塞率为86.3%,未破裂复发组(88.5%)高于破裂组(77.5%)。
- 破裂组1个月并发症率和死亡率高于未破裂复发组。
诊断标准与关键数值
- 总体充分闭塞(完全闭塞和瘤颈残留)率为86.3%。
临床应用与阅片要点
- WEB-17可用于破裂、未破裂复发及非典型位置的颅内动脉瘤,但需注意载瘤动脉与动脉瘤主轴夹角≥45°时可行性降低。
- 术后12个月随访应评估动脉瘤闭塞情况,充分闭塞包括完全闭塞和瘤颈残留。
- 破裂动脉瘤患者术后1个月并发症和死亡风险较高,需加强围手术期管理。
局限性
- 回顾性研究设计。
- 仅纳入两个中心的数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: This retrospective, 2-center study investigated the feasibility, safety, and efficacy at 12-month follow-up of the treatment of ruptured, unruptured, and recurrent intracranial aneurysms using the latest generation of the Woven EndoBridge (WEB) device, the WEB-17 system.
MATERIALS AND METHODS: Aneurysms treated with WEB-17 were extracted from the databases of 2 neurovascular centers. Patients, aneurysm characteristics, complications, and clinical and anatomic results were analyzed.
RESULTS: From February 2017 to May 2021, two hundred twelve patients with 233 aneurysms (181/233, 77.7%, unruptured-recurrent, and 52/233, 22.3%, ruptured) were included. High treatment feasibility (95.3%) was reported and was similar in ruptured aneurysms (94.2%) and unruptured-recurrent aneurysms (95.6%) (P = .71) and in typical (95.4%) and atypical (94.7%) locations (P = .70), but it was lower in aneurysms with an angle between the parent artery and main aneurysm axis of ≥45° (90.2%) compared with those with an angle of <45° (97.1%) (P = .03). Global mortality and morbidity were 1.9% and 3.8% at 1 month, respectively, and 4.4% and 1.9% at 12 months, respectively. One-month morbidity (P = .02) and mortality (P = .003) were higher in the ruptured group (10.0% and 8.0%, respectively) compared with unruptured-recurrent group (1.9% and 0.0%, respectively). Overall adequate occlusion (complete occlusion and neck remnant) was 86.3%. The percentage of adequate occlusion was higher (P = .05) in the unruptured-recurrent group (88.5%) compared with the ruptured group (77.5%).
CONCLUSIONS: The WEB-17 system showed high feasibility for ruptured and unruptured aneurysms, typical and atypical locations, and some aneurysms with an angle of ≥45°. As the most recent generation device, the WEB-17 also demonstrates high safety and good efficacy.
引用
- Pagano, Cortese, Soize, et al. Aneurysm Treatment with Woven EndoBridge-17: Angiographic and Clinical Results at 12 Months from a Retrospective, 2-Center Series. AJNR Am J Neuroradiol. 2023. PMID: 36997284. doi:10.3174/ajnr.A7830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。